P2.5 The identification of a viable outcome measure in the collagen VI myopathies promotes progress toward clinical trials
A.R. Foley, S. Quijano-Roy, J. Collins, V. Straub, N. Deconinck, E. Mercuri, A. D’Amico, E. Bertini, K. North, M. Ryan, C. Rummey, T. Meier, T. Cole, F. Muntoni, C. BönnemannVolume:
21
Année:
2011
Langue:
english
DOI:
10.1016/j.nmd.2011.06.828
Fichier:
PDF, 48 KB
english, 2011
File converter
Plus de résultats de recherche
More benefits 
